Aminohippuric Acid

CHEMBL463 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
194.2 g/mol
LogP
-0.9
Phase
4

Para-aminohippuric acid (PAH) is used as a diagnostic tool to assess kidney function, specifically renal plasma flow and tubular secretory capacity. The kidney almost completely removes it from the blood in a single pass, making the clearance rate a reliable measure of renal blood flow.

Peso molecular

194,1900 g/mol

LogP

-0,90

TPSA

92,40 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Mecanismo de acción

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(C(=O)NCC(=O)O)cc1

InChI

InChI=1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)

Molecular Formula

C9H10N2O3

HBD / HBA

3 / 4

Enlaces Rotables

3

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Para-aminohippuric acid (PAH) is used as a diagnostic tool to assess kidney function, specifically renal plasma flow and tubular secretory capacity. The kidney almost completely removes it from the blood in a single pass, making the clearance rate a reliable measure of renal blood flow.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Aminohippuric Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL463. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2148. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.